Interoperability Mandates and the Free Market: Can Digital Health Innovation Survive Government-Driven Standardization?

Government-mandated interoperability in digital health is no longer hypothetical. The 21st Century Cures Act, the European Health Data Space, and similar initiatives around the world are forcing a level of data standardization that many in the industry once thought impossible. For product teams, compliance officers, and investors, the central question is no longer whether interoperability will be mandated, but whether the resulting environment can still reward innovation. This guide offers a practical framework for thinking about that tension — not from a policy podium, but from the vantage point of teams building and shipping real products.

Where Interoperability Mandates Show Up in Real Product Work

The most immediate place mandates affect product teams is in API design. Under the Cures Act, for example, certified health IT must expose patient data via standardized FHIR APIs. That sounds straightforward until you realize that every endpoint, every data model choice, and every authentication flow now has to align with a spec that is still evolving. Teams building patient-facing apps often find themselves spending 30-40% of their engineering time on compliance plumbing rather than on features that differentiate them in the market.

Another real-world friction point is the scope of data that must be shared. Mandates typically require exposing core clinical data — allergies, medications, problems, lab results — but they rarely require exposing the derived insights or contextual annotations that many apps depend on. A startup that builds a decision-support tool around medication reconciliation may find that the mandated data is a necessary but insufficient foundation; they still need to negotiate separate data-sharing agreements for the higher-value signals that make their product unique.

We also see interoperability mandates affecting procurement decisions inside health systems. When a hospital system evaluates a new digital health tool, one of the first questions is now: 'Does it support FHIR R4? Does it use SMART-on-FHIR for authorization?' Products that don't meet these baseline requirements are often excluded from consideration entirely, regardless of their clinical value. This creates a two-tier market where compliance becomes a prerequisite for entry, and innovation is forced to happen on top of a standardized layer — not outside it.

The catch is that compliance alone doesn't guarantee adoption. Many teams report that even after implementing mandated APIs, they still face resistance from health IT departments concerned about data governance, security reviews, and the operational burden of yet another integration. The mandate opens the door, but it doesn't walk you through it.

What the Cures Act Final Rule Actually Requires

The final rule, published in 2020, requires that certified health IT offer standardized FHIR APIs (version 4 or later) that support read and write access to the Common Clinical Data Set. It also prohibits information blocking — practices that unreasonably limit the exchange of electronic health information. For product teams, this means that if you're building an app that needs access to a patient's records, the health system cannot legally prevent you from getting that data, provided you have patient authorization and meet security requirements.

Where the Mandate Leaves Room for Variation

The rule does not prescribe every detail of the API implementation. There is still room for variation in how authentication is handled, how data is formatted for specific use cases, and how performance is optimized. Teams that treat the mandate as a minimum bar rather than a ceiling often find ways to differentiate — for example, by offering faster response times, richer documentation, or better developer support than competitors who simply check the compliance box.

Foundations Readers Often Confuse: Standardization vs. Uniformity

A common mistake is equating interoperability mandates with a requirement that all products look and behave the same. In practice, mandates standardize the transport and format of data, not the user experience or clinical logic built on top of that data. FHIR defines resources like 'Patient' and 'Observation' with specific fields and data types, but it does not dictate how an app renders a patient timeline or how it calculates a risk score.

Another confusion is between syntactic and semantic interoperability. Most current mandates focus on syntactic interoperability — ensuring that data can be parsed and transmitted between systems. True semantic interoperability, where the meaning of data is preserved across contexts, remains elusive. A lab value of '7.5' might be a glucose measurement in one system and a hemoglobin level in another if the coding system isn't consistently applied. Mandates push toward common vocabularies like LOINC and SNOMED, but they don't eliminate the need for careful mapping and validation.

We also see teams confuse 'open APIs' with 'free access.' Mandated APIs are open in the sense that they follow published standards, but they are not necessarily free. Health systems can charge reasonable fees for API access, subject to information blocking rules. This has led to a patchwork of pricing models that can be confusing for startups trying to budget for integrations.

The Role of Certification Bodies

In the US, the Office of the National Coordinator for Health IT (ONC) oversees the certification program. Products must be tested by an ONC-Accredited Testing Lab to achieve certification. This process adds time and cost to product development, but it also provides a clear benchmark that buyers can trust. Teams often underestimate the lead time required for certification, especially if they need to make changes after initial testing.

Why 'FHIR-Native' Is Not a Panacea

Building a FHIR-native architecture from the start sounds appealing, but it can lock teams into a data model that is optimized for exchange, not for performance or analytics. Many teams find that they need to maintain a separate internal data model for their application logic and then map to FHIR for external APIs. This double-model approach adds complexity but is often necessary for products that need to do more than simply read and write standard clinical data.

Patterns That Usually Work for Balancing Compliance and Innovation

One pattern that consistently succeeds is the compliance layer approach. In this model, the product team builds a thin, standardized API layer that handles all mandated data exchange, while the core application logic remains proprietary and optimized for the specific use case. The compliance layer can be maintained by a dedicated team or even outsourced, freeing the product team to iterate quickly on features that differentiate the product.

Another effective pattern is proactive engagement with health systems. Rather than waiting for a health system to request a specific integration, forward-thinking teams build FHIR-based connectors that are pre-tested and documented. They offer these connectors as part of their standard deployment package, reducing the friction for IT departments. Some teams even publish their API documentation publicly, using it as a marketing tool to demonstrate their commitment to interoperability.

A third pattern is using mandates as a forcing function for data quality. When a product must expose data via standardized APIs, it often reveals inconsistencies and gaps in the underlying data. Teams that invest in data cleaning and normalization as part of their compliance work find that the quality of their analytics and decision-support features improves as a side effect. The mandate becomes a catalyst for internal data hygiene that benefits the entire product.

Building for Extensibility

FHIR allows for extensions — custom fields that can be added to standard resources without breaking compatibility. Teams that design their data models to use extensions for proprietary data can maintain a clean separation between standard and custom information. This approach makes it easier to upgrade to new versions of the FHIR spec without losing product-specific data.

Partnering with EHR Vendors

Some digital health companies have found success by partnering directly with EHR vendors to build certified integrations. These partnerships can provide early access to new API features, co-marketing opportunities, and a smoother path to certification. However, they can also create dependency on a single vendor, which carries its own risks.

Anti-Patterns and Why Teams Revert to Them

The most common anti-pattern we observe is the over-engineered compliance layer. Teams, especially those with strong regulatory backgrounds, sometimes build an API layer that is far more complex than what the mandate requires. They add every possible feature from the FHIR spec, even features that are not yet used by any client. This bloats the codebase, slows development, and creates maintenance burdens that drain resources from innovation.

Another anti-pattern is treating compliance as a one-time project. Mandates evolve — FHIR releases new versions, information blocking rules get clarified, and certification requirements change. Teams that treat interoperability as a checkbox to be ticked and forgotten often find themselves scrambling when a new requirement emerges. The better approach is to embed compliance into the continuous development cycle, with regular reviews and updates.

We also see teams over-indexing on the minimum viable product for compliance. They implement the bare minimum set of data elements and API endpoints, reasoning that they can add more later. In practice, this often leads to a poor developer experience for potential integration partners, who find the API too limited to build useful applications. The result is that the product gets certified but never actually gets used, defeating the purpose of the mandate.

The 'Not Invented Here' Trap

Some teams resist using existing open-source FHIR implementations, preferring to build their own from scratch. While this gives them full control, it often leads to reinventing the wheel and introduces bugs that the community has already fixed. Unless a team has very specific needs that are not met by existing libraries, using a well-maintained open-source FHIR server is usually the faster and more reliable path.

Ignoring the Developer Experience

Mandated APIs are only useful if developers can actually use them. Teams that focus solely on the technical specification and neglect documentation, sample code, and sandbox environments often find that their API adoption is low. A well-documented API with clear examples and a test environment can be a competitive advantage.

Maintenance, Drift, and Long-Term Costs of Interoperability Mandates

One of the hidden costs of interoperability mandates is the ongoing maintenance burden. APIs must be updated as standards evolve, and each update requires testing, certification, and communication with integration partners. For a small startup, this can consume a significant portion of the engineering budget. Over time, the cost of maintaining compliance can exceed the cost of the initial implementation.

Another long-term cost is technical drift. As the product evolves, the internal data model may diverge from the FHIR model used in the compliance layer. Teams must invest in ongoing mapping and transformation logic to keep the two aligned. If this mapping is not maintained, the API may start returning incomplete or inaccurate data, eroding trust with partners.

There is also the risk of regulatory drift — changes in the regulatory environment that require significant rework. For example, if a new version of FHIR becomes mandatory, teams may need to overhaul their API layer. The uncertainty around future mandates makes it difficult to plan long-term roadmaps.

Cost of Certification Renewal

Certification is not a one-time event. Products must be recertified periodically, and any significant change to the API may trigger a new certification cycle. The cost of testing and documentation for recertification can be substantial, especially for products with complex APIs.

Opportunity Cost of Compliance Work

Every hour spent on compliance is an hour not spent on product features, user research, or marketing. For startups, this opportunity cost can be the difference between reaching product-market fit and running out of runway. Teams need to be strategic about how much compliance work is truly necessary versus what can be deferred or simplified.

When Not to Use This Approach: Cases Where Mandates May Stifle Innovation

There are situations where the cost of compliance clearly outweighs the benefits. For example, a startup building a niche clinical decision support tool for a rare disease may find that the mandated data sets are irrelevant to their use case. The effort required to implement FHIR APIs for data that no one will ever request may be better spent on improving the algorithm or user interface.

Another case is products that rely on real-time streaming data rather than discrete clinical records. Mandated APIs are typically designed for request-response interactions, not for continuous data feeds. Teams building remote monitoring platforms or AI-based alerting systems may find that the standard APIs are too slow or too limited for their needs. In such cases, it may be more effective to use alternative data exchange mechanisms, even if they are not mandated.

We also see situations where the target market is outside the jurisdiction of the mandate. A digital health company focused on providing services to employers or wellness programs may not need to comply with healthcare-specific mandates at all. Building a compliance layer in that context would be unnecessary overhead.

When Proprietary APIs Are a Better Fit

If the product's value proposition depends on a unique data model or a specialized workflow that doesn't map well to FHIR, a proprietary API may be more appropriate. The key is to be transparent with partners about the data model and to provide robust documentation. In some cases, a proprietary API can actually be a competitive differentiator, as long as it is well-designed and easy to use.

When the Mandate Is Still in Flux

If the regulatory environment is uncertain — for example, if a new administration is likely to change the rules — it may be prudent to wait before investing heavily in compliance. Building a flexible architecture that can adapt to different standards is often a better use of resources than committing to a specific implementation that may become obsolete.

Open Questions and Unresolved Tensions

One of the biggest open questions is whether interoperability mandates will eventually lead to commoditization of health IT. If every product must expose the same data in the same format, what room is left for differentiation? The answer may lie in the layers above the API — in user experience, analytics, and workflow integration — but that is not guaranteed. Some fear that the market will consolidate around a few large platforms that can afford the compliance costs, squeezing out smaller innovators.

Another unresolved tension is between patient access and data privacy. Mandates that require easy access to data also increase the risk of data breaches and misuse. The FHIR security model relies on OAuth2 and SMART-on-FHIR, but implementation varies widely. As more data flows through standardized APIs, the attack surface grows. Teams must invest in security measures that go beyond the minimum requirements.

Finally, there is the question of global harmonization. Different countries and regions have different interoperability standards and mandates. A product that complies with US regulations may not work in Europe, and vice versa. This fragmentation creates additional complexity for companies that want to operate internationally. The push for global standards like FHIR is promising, but the pace of adoption is uneven.

What the Future Might Hold

We are likely to see more granular mandates over time — requirements not just for data access, but for specific use cases like prior authorization, care coordination, and public health reporting. Teams that build flexible, standards-based architectures now will be better positioned to adapt to these future requirements. The key is to view interoperability not as a burden, but as a strategic capability that can open new markets and partnerships.

Next Steps for Product Teams

First, audit your current product against the relevant mandates in your target markets. Identify gaps and prioritize them based on market demand and regulatory deadlines. Second, invest in a compliance layer that is decoupled from your core product logic, so that changes to one do not require changes to the other. Third, engage with health systems and integration partners early to understand their real-world needs and pain points. Fourth, contribute to open-source FHIR projects and standards development — it's a way to influence the direction of the technology while building credibility. Finally, keep a close eye on regulatory developments and be prepared to pivot your strategy as the landscape evolves.